Joel Dunn

Joel Dunn

Auto-generated profile, based on publicly available information

Joel Dunn

School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
GKGeorgios Krokos
Georgios Krokos
JMJane MacKewn
Jane MacKewn
JDJoel Dunn
Joel Dunn
PMPaul Marsden
Paul Marsden
Despite being thirteen years since the installation of the first PET-MR system, the scanners constitute a very small proportion of the total hybrid PET systems installed. This is in stark contrast to the rapid expansion of the PET-CT scanner, which quickly established its importance in patient diagnosis within a similar timeframe. One of the main hurdles is the development of an accurate, reproducible and easy-to-use method for attenuation correction. Quantitative discrepancies in PET images between the manufacturer-provided MR methods and the more established CT- or transmission-based attenuation correction methods have led the scientific community in a continuous effort to develop a robust and accurate alternative. These can be divided into four broad categories: (i) MR-based, (ii) emission-based, (iii) atlas-based and the (iv) machine learning-based attenuation correction, which is rapidly gaining momentum. The first is based on segmenting the MR images in various tissues and allocating a predefined attenuation coefficient for each tissue. Emission-based attenuation correction methods aim in utilising the PET emission data by simultaneously reconstructing the radioactivity distribution and the attenuation image. Atlas-based attenuation correction methods aim to predict a CT or transmission image given an MR image of a new patient, by using databases containing CT or transmission images from the general population. Finally, in machine learning methods, a model that could predict the required image given the acquired MR or non-attenuation-corrected PET image is developed by exploiting the underlying features of the images. Deep learning methods are the dominant approach in this category. Compared to the more traditional machine learning, which uses structured data for building a model, deep learning makes direct use of the acquired images to identify underlying features. This up-to-date review goes through the literature of attenuation correction approaches in PET-MR after categorising them. The various approaches in each category are described and discussed. After exploring each category separately, a general overview is given of the current status and potential future approaches along with a comparison of the four outlined categories.

20 September 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
CCCornelia Carey
Cornelia Carey
NSNisha Singh
Nisha Singh
JDJoel T. Dunn
Joel T. Dunn
TSTeresa Sementa
Teresa Sementa
MMMaria Andreina Mendez
Maria Andreina Mendez
GMGrainne McAlonan
Grainne McAlonan
The metabotropic glutamate receptor 5 (mGluR5) is a key regulator of excitatory (E) glutamate and inhibitory (I) γ-amino butyric acid (GABA) signalling in the brain. Despite the close functional ties between mGluR5 and E/I signalling, no-one has directly examined the relationship between mGluR5 and glutamate or GABA in vivo in the human brain of autistic individuals. We measured [18F] FPEB (18F-3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile) binding in 15 adults (6 with Autism Spectrum Disorder) using two regions of interest, the left dorsomedial prefrontal cortex and a region primarily composed of left striatum and thalamus. These two regions were mapped out using MEGA-PRESS voxels and then superimposed on reconstructed PET images. This allowed for direct comparison between mGluR5, GABA + and Glx. To better understand the molecular underpinnings of our results we used an autoradiography study of mGluR5 in three mouse models associated with ASD:Cntnap2knockout,Shank3knockout, and16p11.2deletion. Autistic individuals had significantly higher [18F] FPEB binding (t(13) = −2.86,p = 0.047) in the left striatum/thalamus region of interest as compared to controls. Within this region, there was a strong negative correlation between GABA + and mGluR5 density across the entire cohort (Pearson’s correlation:r(14) = −0.763,p = 0.002).Cntnap2KO mice had significantly higher mGlu5 receptor binding in the striatum (caudate-putamen) as compared to wild-type (WT) mice (n = 15,p = 0.03). There were no differences in mGluR5 binding for mice with theShank3knockout or16p11.2deletion. Given thatCntnap2is associated with a specific striatal deficit of parvalbumin positive GABA interneurons and ‘autistic’ features, our findings suggest that an increase in mGluR5 in ASD may relate to GABAergic interneuron abnormalities.

12 August 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
KBKatherine Beck
Katherine Beck
AAAtheeshaan Arumuham
Atheeshaan Arumuham
MVMattia Veronese
Mattia Veronese
BSBarbara Santangelo
Barbara Santangelo
CMColm J. McGinnity
Colm J. McGinnity
OHOliver D. Howes
Oliver D. Howes
N-methyl-D-aspartate receptor (NMDAR) hypofunction is hypothesised to underlie psychosis but this has not been tested early in illness. To address this, we studied 40 volunteers (21 patients with first-episode psychosis and 19 matched healthy controls) using PET imaging with an NMDAR selective ligand, [18F]GE-179, that binds to the ketamine binding site to index its distribution volume ratio (DVR) and volume of distribution (VT). Hippocampal DVR, but not VT, was significantly lower in patients relative to controls (p = 0.02, Cohen’s d = 0.81; p = 0.15, Cohen’s d = 0.49), and negatively associated with total (rho = −0.47, p = 0.04), depressive (rho = −0.67, p = 0.002), and general symptom severity (rho = −0.74, p < 0.001). Exploratory analyses found no significant differences in other brain regions (anterior cingulate cortex, thalamus, striatum and temporal cortex). These findings are consistent with the NMDAR hypofunction hypothesis and identify the hippocampus as a key locus for relative NMDAR hypofunction, although further studies should test specificity and causality.

1 May 2015 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
TSTeresa A. Szyszko
Teresa A. Szyszko
JDJoel T. Dunn
Joel T. Dunn
MOMichael J. O’doherty
Michael J. O’doherty
LRLaurence Reed
Laurence Reed
JLJean-Pierre Lin
Jean-Pierre Lin
No current neuroimaging modality offers mechanistic or prognostic information to guide management in paediatric dystonia. We assessed F-fluorodeoxyglucose (¹⁸F-FDG) PET/computed tomography (CT) brain imaging in childhood primary dystonia (PDS) and neurodegeneration with brain iron accumulation (NBIA) to determine whether it would identify altered metabolism and hence constitute a potentially useful 'biomarker' indicating functional disturbances associated with dystonia and severity of the disease. A total of 27 children (15 PDS and 12 NBIA) underwent brain ¹⁸F-FDG PET/CT imaging under anaesthesia during acquisition. The images were assessed visually and the two groups were compared quantitatively with statistical parametric mapping. PET/CT images were spatially transformed to Montreal Neurological Institute standard space. Voxelwise ¹⁸F-FDG uptake was normalized to whole-brain uptake. Data of both groups were correlated separately with duration and severity of dystonia as assessed using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS). Visual inspection did not identify any abnormalities in ¹⁸F-FDG uptake within the cerebral cortex, basal ganglia, or thalami in either group. Quantitative analysis identified higher uptake in the posterior cingulate and bilateral posterior putamina but decreased uptake in the occipital cortex and cerebellum in NBIA compared with PDS. The NBIA group had more severe dystonia scores compared with the PDS group. BFMDRS was negatively correlated with age but not with duration of dystonia. Compared with PDS, NBIA is dominated by relative overactivity in the putamen and by cerebellar underactivity, patterns that may reflect the increased severity of dystonia in NBIA cases. Hence, there is a potential role for ¹⁸F-FDG PET/CT imaging in paediatric dystonia, particularly in the NBIA group.

27 October 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMArick Sagel Martinez
Arick Sagel Martinez
AFAnthime FLAUS
Anthime FLAUS
RHRolf A. Heckemann
Rolf A. Heckemann
JDJoel Dunn
Joel Dunn
SASufian Al-Ethawi
Sufian Al-Ethawi
AHAlexander Hammers
Alexander Hammers
There is limited evidence on the advantages of brain 2-deoxy-2-[ 18 F]fluoroglucose (FDG) positron emission tomography (PET) with simultaneous magnetic resonance imaging (PET-MR) over PET with computed tomography (PET/CT). We quantitatively compared brain FDG PET/CT and PET-MR images from a large clinical cohort. Participants with refractory epilepsy or cognitive problems underwent PET/CT at approximately 30 min post-injection, followed by PET-MR at approximately 100 min. Standardized uptake values (SUVs) were extracted in anatomical regions using a multi-atlas method, and voxel-wise comparisons were performed with statistical parametric mapping. Fifty-five image pairs passed quality control. Within-subject correlations between modalities were very high (0.96, range 0.84–0.99); within-region, across-participant correlations were 0.82 (0.72–0.90). PET-MR SUVs were on average 20% higher than PET/CT, more so for higher-uptake regions. Voxel-wise, PET-MR showed relatively higher uptake in visual and auditory cortices, lower uptake in medial frontal and anteromesial temporal cortices, and better grey-white matter contrast. We found a very close correspondence between the two modalities with their respective attenuation correction methods and sensory activation between scans; the different uptake times explain differences in absolute SUV levels and grey-white matter contrast. With awareness of these differences, brain PET-MR can be used clinically.

22 July 2025 in bioRxiv
Verified
Preprint
Open access
YYYeo-Jin Yi
Yeo-Jin Yi
JJJarkko Johansson
Jarkko Johansson
BGBerta Garcia-Garcia
Berta Garcia-Garcia
PSPeter Schulze
Peter Schulze
KBKathrin Baldauf
Kathrin Baldauf
DHDorothea Hämmerer
Dorothea Hämmerer
Cognitive ageing is marked by progressive decline in episodic memory and dopaminergic function, yet the extent to which individual differences in dopaminergic system integrity influence memory under motivational contexts remains unclear. In this study, we investigated how baseline D2/D3 receptor availability (BP ND 0 ) in key dopaminergic pathways relates to reward-modulated memory performance in healthy older adults. Thirty-three healthy seniors (aged 64-85) underwent two session concurrent MR-PET imaging with [ 1 F]fallypride involving scene categorisation task with high- and low-motivational contexts. We quantified BP ND 0 across nine dopaminergic regions of interest and examined their relationships with recognition memory performance at short (∼15m) and long (∼24h) delays. Baseline D2/D3 receptor availability showed high test-retest reliability and regionally distinct profiles, suggesting it reflects a stable neurochemical characteristic in healthy ageing, and principal axis factor analysis revealed two partially independent dopaminergic subsystems (dorsal striatal vs mesolimbic) based on interindividual patterns in receptor densities. Region-specific associations further linked D2/D3 receptor availability to distinct memory outcomes. Higher caudate D2/D3 receptor availability was associated with a liberal response bias (increased hits and false alarms both), whereas higher putamen D2/D3 predicted more durable long-term memory retention. Greater thalamic D2/D3 receptor availability correlated with fewer short-term false memories, while greater D2/D3 receptor availability in the amygdala was associated with better recognition at longer delays. In contrast, higher midbrain (substantia nigra and ventral tegmental area) D2/D3 availability which was linked to poorer reward-related memory performance. These findings suggest several complementary dopaminergic circuits supporting episodic memory. Our results highlight dopaminergic neuromodulation as a key factor in cognitive ageing and a potential target for interventions to bolster memory in late life. Patient consent and ethics approval: All subjects who were included in this study have provided their consent prior to their participation, following the guidelines of the ethics committee at University Hospital Magdeburg in Magdeburg, Germany.